Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,755 public trials 967 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

NCT04425200

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi Anemia, Complementation Group D1, +19 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
View all 26 locations
View Trial Details
Completed

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02711956

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute Farmington Hills, Michigan, United States
View Trial Details
Completed

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02737332

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Alliance Research Laguna Hills, California, United States
  • Tower Urology Los Angeles, California, United States
  • San Bernardino Urological San Bernardino, California, United States
  • Skyline Urology Torrance, California, United States
View all 17 locations
View Trial Details
Completed

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

NCT01751451

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Karmanos Cancer Institute, Wayne State University Detroit, Michigan, United States
  • Urology Cancer Center and GU Research Network Omaha, Nebraska, United States
View all 16 locations
View Trial Details
Completed

Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients

NCT03120832

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Dr. James J. Elist Beverly Hills, California, United States
  • GU Research Network/Urology Cancer Center Omaha, Nebraska, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details

Related conditions